Total Number of Communication Reports: 5
Monthly communication reports in the last 6 months: 0
End date of the last completed financial year: 2019-12-19
Government Institution | Funding Received in Last Financial Year | Funding Expected in Current Financial Year |
---|---|---|
Innovation, Science and Economic Development Canada (ISED) | $0.00 | Yes |
Address:
First Canadian Place, 34th Floor, 100 King St. W.
Toronto, ON M2N 6N4
Canada
Telephone number:
617-818-2172
David Goren, CEO, Chairman
Vaxil Biotherapeutics is not a subsidiary of any other parent companies.
Vaxil Biotherapeutics is not a coalition.
The activities of Vaxil Biotherapeutics are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Vaxil Biotherapeutics does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
LESTER SCHEININGER | No public offices held
Firm: Lester Scheininger, Barrister and Solicitor